KUALA LUMPUR, 26 August 2025 – DC Healthcare Holdings Berhad (DC Healthcare or the Group), a leading provider of non-invasive and minimally invasive aesthetic services, posted another strong set of results for the second quarter ended 30 June 2025 (Q2 FY2025), underlining its position in Malaysia’s fast-growing wellness market.
The Group recorded RM20.60 million in revenue, a 48% increase from RM13.88 million in Q2 FY2024, driven primarily by stronger redemptions of aesthetic packages and higher cash sales. The aesthetic segment contributed RM17.80 million, or 86% of total revenue, marking a 53% year-on-year jump. Gross profit more than doubled to RM10.45 million from RM5.19 million previously, reflecting improved service delivery and operational efficiency.
Loss before tax (LBT) narrowed significantly to RM1.03 million, compared with RM6.71 million in Q2 FY2024, signalling a continued turnaround.
Half-Year Momentum Strengthens
For the first half of FY2025 (1H FY2025), DC Healthcare reported RM38.50 million in revenue, up 65% from RM23.34 million a year earlier. Gross profit soared to RM19.57 million from RM6.41 million, while LBT improved sharply to RM1.87 million from RM14.62 million.
On a quarter-on-quarter basis, revenue rose 15% from RM17.90 million in Q1 FY2025, reflecting sustained demand and stronger sales conversion. However, LBT edged higher to RM1.03 million from RM0.84 million, mainly due to a one-off disposal of medical equipment, which resulted in a RM0.70 million loss.
Strategic Priorities
Managing Director Dr. Chong Tze Sheng said the second quarter results highlight the Group’s resilience and growth potential.
“Our performance underscores strong consumer demand for aesthetic treatments and effective execution of our strategy. While we recorded a one-off disposal expense, our fundamentals remain robust with consistent topline growth and gross profit expansion. We will continue to prioritise cost discipline, patient engagement, and integrated brand growth,” he said.
The Group is sharpening its focus on key strategic pillars:
- Brand Synergies: Leveraging its Dr. Chong Clinic, Dr. Chong Slimming, and NewB Premium Skincare brands to build a holistic ecosystem.
- Patient Engagement: Deploying AI-assisted skin analysis and personalised treatment plans to strengthen patient outcomes and retention.
- Operational Efficiency: Rolling out a Group-wide efficiency programme and an enterprise resource planning (ERP) system to enhance inventory control, resource allocation, and data-driven management.
- Expansion Plans: Moving ahead with the acquisition of a three-storey end-lot shop in Bandar Kinrara, Puchong for RM8.0 million, aimed at reducing long-term leasing costs and supporting clinic network growth.
Outlook
With Malaysia’s aesthetic and wellness market expanding rapidly, DC Healthcare is well-positioned to capture further growth through service innovation, digital engagement, and operational strengthening.
“These initiatives will reinforce our leadership in the sector and create long-term value for our stakeholders,” Dr. Chong added.
